We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+33%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$19.5B
AUM Growth
+$4.67B
Cap. Flow
+$750M
Cap. Flow %
3.84%
Top 10 Hldgs %
35.61%
Holding
917
New
102
Increased
528
Reduced
232
Closed
53

Sector Composition

Rank Sector Weight
1 Materials 57.74%
2 Energy 17%
3 Healthcare 5.04%
4 Industrials 2.41%
5 Technology 2.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGNC icon
201
AGNC Investment
AGNC
$12.3B
$9.79M 0.05%
493,885
+25,162
+5% +$475K
XHB icon
202
State Street SPDR S&P Homebuilders ETF
XHB
$1.71B
$9.78M 0.05%
+291,535
New +$9.85M
WMT icon
203
Walmart Inc
WMT
$863B
$9.6M 0.05%
394,257
-78,621
-17% -$1.82M
LRCX icon
204
Lam Research
LRCX
$400B
$9.47M 0.05%
1,126,230
+487,660
+76% +$3.92M
NGL icon
205
NGL Energy Partners
NGL
$2.01B
$9.35M 0.05%
483,799
+15,691
+3% +$218K
XLY icon
206
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.3B
$9.35M 0.05%
239,428
-285,976
-54% -$11.3M
ALKS icon
207
Alkermes
ALKS
$8.83B
$9.25M 0.05%
213,985
-25,469
-11% -$1.05M
ACAS
208
DELISTED
American Capital Ltd
ACAS
$8.88M 0.05%
560,729
-44,923
-7% -$710K
MCHP icon
209
Microchip Technology
MCHP
$44.2B
$8.62M 0.04%
339,776
+170,918
+101% +$4.26M
ALNY icon
210
Alnylam Pharmaceuticals
ALNY
$35.9B
$8.61M 0.04%
155,123
-16,756
-10% -$1.06M
NBIX icon
211
Neurocrine Biosciences
NBIX
$17.5B
$8.6M 0.04%
+189,172
New +$8.71M
NVG icon
212
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.66B
$8.57M 0.04%
527,354
+456,127
+640% +$7.14M
PSEC icon
213
Prospect Capital
PSEC
$1.06B
$8.52M 0.04%
1,089,196
+54,610
+5% +$411K
TLK icon
214
Telkom Indonesia
TLK
$14.2B
$8.49M 0.04%
276,156
-75,306
-21% -$2.09M
ETN icon
215
Eaton
ETN
$161B
$8.35M 0.04%
139,853
-12,940
-8% -$795K
TSLA icon
216
Tesla
TSLA
$1.26T
$8.13M 0.04%
574,110
-89,505
-13% -$1.36M
MXIM
217
DELISTED
Maxim Integrated Products
MXIM
$7.9M 0.04%
221,387
+100,917
+84% +$3.7M
EXCU
218
DELISTED
Exelon Corporation
EXCU
$7.85M 0.04%
159,162
+42,857
+37% +$2.06M
ANTX
219
DELISTED
Anthem, Inc.
ANTX
$7.74M 0.04%
173,003
+46,584
+37% +$2.13M
KRE icon
220
State Street SPDR S&P Regional Banking ETF
KRE
$4.82B
$7.51M 0.04%
+195,520
New +$7.73M
SGEN
221
DELISTED
Seagen Inc. Common Stock
SGEN
$7.33M 0.04%
181,517
-39,548
-18% -$1.5M
LLTC
222
DELISTED
Linear Technology Corp
LLTC
$7.3M 0.04%
156,856
+76,552
+95% +$3.5M
AGCO icon
223
AGCO
AGCO
$8.49B
$7.25M 0.04%
153,815
+17,769
+13% +$912K
NUE icon
224
Nucor
NUE
$54.9B
$7.24M 0.04%
146,616
+47,421
+48% +$2.31M
TSNU
225
DELISTED
Tyson Foods, Inc.
TSNU
$7.21M 0.04%
97,649
-54,054
-36% -$3.89M

Similar funds

VanEck Associates's Q2 2016 Portfolio in Review

As of Q2 2016, VanEck Associates held 917 positions worth $19.5B, up 31% from $14.8B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

VanEck Associates deployed $750M of net new capital in Q2 2016, opening 102 new positions and adding to 528 existing holdings. Its largest new stake was Innovex International: 334,392 shares worth $19.5M.

By sector, the portfolio is most concentrated in Materials at 58% of assets, up from 48% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Valero Energy, an estimated $134M trimmed.

  • VanEck Associates's largest Q2 2016 buy was Innovex International: 334,392 shares worth $19.5M.
  • VanEck Associates added most to Newmont in Q2 2016, an estimated $271M increase.
  • VanEck Associates's biggest Q2 2016 reduction was Valero Energy, cutting an estimated $134M.
  • VanEck Associates fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $45.1M.
  • VanEck Associates's ten largest holdings make up 36% of its $19.5B portfolio in Q2 2016.
  • VanEck Associates opened 102 new positions and closed 53 in Q2 2016.
  • VanEck Associates's portfolio value rose 31% quarter-over-quarter to $19.5B.

Based on VanEck Associates's 13F filing for Q2 2016, filed 12 Aug 2016.